Naloxone Auto-injection in Healthy Volunteers
Launched by UNIVERSITY OF WASHINGTON · Oct 28, 2021
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy male/female volunteers
- • \>18 years
- • No allergy to naloxone or ingredients in its formulation
- • Ability to read and understand English
- • Written informed consent obtained from subject
- • Ability to comply with study requirements
- Exclusion Criteria:
- • History of alcohol or substance abuse
- • History of unusual pain sensitivity, lack of sensitivity
- • History of chronic myofascial, inflammatory, neuropathic pain
- • Chronic use of medication known to interfere with naloxone
- • Pregnant women and nursing mothers
- • Presence of a condition or abnormality that in the opinion of the Principal Investigator would compromise subject safety or the quality of the data (e.g., persons with liver disease, renal insufficiency/failure)
- • Alcohol on the breath
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Jacob Sunshine, MD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials